Reaction
Facial Spasm reporting signals
As of the last recalculation, Facial Spasm appears in 1,107 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ONABOTULINUMTOXINA (PRR 20.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Onabotulinumtoxina | 77 | 20.1 | 20.1 |
| Cariprazine | 9 | 18.3 | 18.3 |
| Botulinum Toxin Type A | 9 | 13.7 | 13.7 |
| Lurasidone Hydrochloride | 15 | 13.6 | 13.7 |
| Brivaracetam | 6 | 12.6 | 12.6 |
| Memantine | 8 | 11.1 | 11.1 |
| Memantine Hydrochloride | 8 | 11.1 | 11.1 |
| Asenapine Maleate | 5 | 10.9 | 10.9 |
| Ziprasidone | 9 | 9.7 | 9.7 |
| Suvorexant | 5 | 7.3 | 7.3 |
| Diroximel Fumarate | 4 | 6.3 | 6.3 |
| Vigabatrin | 4 | 5.2 | 5.2 |
| Galcanezumab-Gnlm | 4 | 2.4 | 2.4 |
| Valbenazine | 3 | 2.2 | 2.2 |